# David Avigan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-avigan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,721 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 60 |
| i10-index | 168 |
| Last Known Institution | Beth Israel Deaconess Medical Center |
| OpenAlex ID | https://openalex.org/A5052641327 |
| ORCID iD | https://orcid.org/0000-0003-4624-6017 |
| Works | 563 |

## Researcher papers

- [Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study](https://scholariq.org/papers/ciltacabtagene-autoleucel-a-b-cell-maturation-antigen-directed-chimeric-antigen/)
- [Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma](https://scholariq.org/papers/lenalidomide-bortezomib-and-dexamethasone-combination-therapy-in-patients-with/)
- [Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial](https://scholariq.org/papers/disabling-immune-tolerance-by-programmed-death-1-blockade-with-pidilizumab-after/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)

## Researcher university

- [Beth Israel Deaconess Medical Center](https://scholariq.org/institutions/beth-israel-deaconess-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.